Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An elongated and multinodular neurofibroma, formed when the tumor involves either multiple trunks of a plexus or multiple fascicles of a large nerve, such as the sciatic. Some plexiform neurofibromas resemble a bag of worms, others produce a massive ropy enlargement of the nerve. (Adapted from WHO.)
Biomarker and diagnostic research for plexiform neurofibroma has been reported in the published literature.
21 clinical trials registered, 7 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 3 PHASE3, 6 PHASE2, 5 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07407803](https://clinicaltrials.gov/study/NCT07407803) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:52 PM UTC
Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas |
PHASE3 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
RECRUITING |
[NCT06502171](https://clinicaltrials.gov/study/NCT06502171) | Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas | PHASE1 | Girish Dhall, MD | RECRUITING |
[NCT06188741](https://clinicaltrials.gov/study/NCT06188741) | Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 | PHASE2 | University of Alabama at Birmingham | RECRUITING |
[NCT06961565](https://clinicaltrials.gov/study/NCT06961565) | PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas | PHASE1 | Pasithea Therapeutics Corp. | RECRUITING |
[NCT05199376](https://clinicaltrials.gov/study/NCT05199376) | Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1 | NA | Centre Leon Berard | RECRUITING |
191 publications have been identified in PubMed for plexiform neurofibroma. Research spans Case Report / Case Series (41%), Clinical Trial Publication (14%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 78 | 41% |
Clinical study results | 27 | 14% |
Laboratory research | 26 | 14% |
Research summaries | 25 | 13% |
Disease patterns and progression | 19 | 10% |
New treatment approaches | 10 | 5% |
Testing and diagnosis research | 4 | 2% |
Other research | 2 | 1% |
Ak EB (2026). [PMID: 41625572](https://pubmed.ncbi.nlm.nih.gov/41625572/). *Radiology case reports*. [Case Report / Case Series]
Mahtab P (2026). [PMID: 41914105](https://pubmed.ncbi.nlm.nih.gov/41914105/). *Mymensingh Med J*. [Epidemiology / Natural History]
Liu C (2026). [PMID: 42153678](https://pubmed.ncbi.nlm.nih.gov/42153678/). *J Pediatr Ophthalmol Strabismus*. [Case Report / Case Series]
Friedrich RE (2026). [PMID: 41487931](https://pubmed.ncbi.nlm.nih.gov/41487931/). *Cancer Diagn Progn*. [Epidemiology / Natural History]
Sun S (2026). [PMID: 41580779](https://pubmed.ncbi.nlm.nih.gov/41580779/). *Cancer Cell Int*. [Clinical Trial Publication]
Kumar N (2026). [PMID: 41824205](https://pubmed.ncbi.nlm.nih.gov/41824205/). *J Ultrasound*. [Gene Therapy / Novel Therapeutics]
Prat C (2026). [PMID: 41999864](https://pubmed.ncbi.nlm.nih.gov/41999864/). *Actas Dermosifiliogr*. [Review / Meta-Analysis]
Armstrong AE (2026). [PMID: 41645458](https://pubmed.ncbi.nlm.nih.gov/41645458/). *Neuro Oncol*. [Review / Meta-Analysis]
Li J (2026). [PMID: 42010298](https://pubmed.ncbi.nlm.nih.gov/42010298/). *Eye (Lond)*. [Case Report / Case Series]
Kotch C (2026). [PMID: 42059002](https://pubmed.ncbi.nlm.nih.gov/42059002/). *Neurooncol Adv*. [Review / Meta-Analysis]
AI-curated news mentioning plexiform neurofibroma
Updated Aug 4, 2026
A recent study details the staged resection and reconstruction of a 60 kg giant plexiform neurofibroma affecting the posterior trunk and thigh. This case highlights surgical approaches to managing large neurofibromas, contributing to the understanding of treatment options.